NewslettersPulmonary Cell NewsLigand-Independent EphA2 Contributes to Chemoresistance in Small-Cell Lung Cancer by Enhancing PRMT1-Mediated SOX2 MethylationBy Jamie Kang - November 16, 20220460Investigators tested whether ligand-independent activation of EphA2 modulated chemoresistance by enhancing stemness in SCLC.[Cancer Science]Abstract